First in Europe, Second in the World

So You Know Your Trial Will Run Efficiently & Effectively

  • Staffed office since 2004
  • Country Manager is a biochemist with extensive clinical research experience and over a decade of service to Pharm-Olam International
  • Dedicated in-house Regulatory Manager
  • Very low staff turnover
  • A good mix of well experienced staff as well as newcomers in the industry
  • Pharm-Olam is a proud member of BeCRO, the Belgian Association of CROs


Belgium Map



Accessible Patient Population

Connected, Accessible Patient Population

Patients are available, urban-concentrated and highly connected.

  • Urban population is 97.9% of total population as of 2015
  • Three official languages: Dutch, French, German
  • Low infant mortality rate: 3.41 deaths/1,000 live births
  • 9.5 million Internet Users, percent of population: 84.7% (2014 est.)

A World Leader for Clinical Trials

A World Leader for Clinical Trials

Established sites boast excellent track records for successful studies.

  • Over 400 clinical trials performed in Belgium each year
  • More than 170,000 Belgian patients participate in Phase II and III trials each year
  • In 2014, 1,500 clinical trials ran in Belgian with more than 270 Pediatric studies
  • Top domains of research include Oncology, Cardiovascular, Central Nervous System diseases & Respiratory
Abundant Resources, Expeditious Processes

Abundant Resources, Expeditious Processes

Belgium boasts a ready-made infrastructure for your trial.

  • Experienced, educated healthcare provides support an R&D intensive culture
  • Short approval timelines are respected
  • Highly qualified & competent authorities & ethics committees
What Our Clients Say

What Our Clients Say

Timelines achieved and open communication

"Senior Management and Pharm-Olam teams were available and remained flexible at all times, responding quickly to all requests to ensure customer expectations were met throughout the study."

- Associate Director, Clinical Operations


See why working with Pharm-Olam in Belgium could be the best choice for your next study.

Contact Us